BETHESDA, Md.--(BUSINESS WIRE)--Telcare, Inc., an award-winning medical device and IT company, is now offering a revolutionary diabetes management system to business owners and their employees nationwide through the Verizon Partner Program. Telcare’s cellular-enabled blood glucose meter allows people with diabetes to get real-time coaching from healthcare professionals, thereby improving diabetes control and managing the cost of care for employers.
Nearly 30 million – one in ten – Americans have diabetes. Compared to employees without diabetes, the average employee with diabetes costs a self-insured employer approximately $7,000 per year in excess healthcare spending and an additional $3,000 per year in lost productivity, according to the American Diabetes Association.1
Telcare’s diabetes management system starts with a cellular-enabled blood glucose meter that taps the power of Verizon’s nationwide wireless network to transmit glucose values to a secure server where patients and their doctors can access the information. Automated and healthcare professional-directed guidance and coaching are simultaneously displayed on the device, on patients’ and their loved ones’ phones, and on the secure internet patient portal. The information from Telcare’s meter can also go directly to the medical record of any doctor the patient selects. As part of Verizon’s focus on the healthcare market, Telcare worked with the Verizon Innovation Center in Waltham, Mass. to certify the device on the company’s wireless networks.
Telcare’s product is already used by some of the nation’s largest health insurers, Medicare and Medicaid plans, and government employee health plans. Now, as a Silver member of the Verizon Partner Program, the Verizon sales force will offer Telcare’s product as part of the company’s broad array of connected devices for businesses nationwide.
“Employers are searching for ways to help their employees manage diabetes and other chronic diseases that have caused healthcare costs to spiral out of control,” said Dr. Jonathan Javitt, Telcare’s CEO and Vice Chairman. “Telcare’s system enables people with diabetes to share real-time data over a reliable network and communicate immediately with a healthcare professional at the teachable moment – that moment when they are wondering what to do next. Scientific evidence from national and international studies has long shown that even a 10 percent improvement in blood sugar levels reduces complications of diabetes by about 40 percent.2,3 With Telcare’s diabetes management system, we finally have a tool that can be put in the patient’s hand to help achieve those results.”
The Telcare system can make a significant difference to business owners who are struggling with rapidly rising employee health costs. A study published in the Winter 2014 edition of US Endocrinology shows an estimated $3,300 reduction in annual employee healthcare costs for employees with diabetes associated with the use of Telcare’s system combined with telephonic coaching.4 Moreover, implementing the system is highly cost-effective, since Telcare’s system is priced comparably to the ordinary blood glucose meters and test strips already reimbursed by all health insurers.
Telcare uses award-winning cellular machine-to-machine technology to bridge the last mile between patients and their caregivers in order to improve the care of chronic illness. Telcare’s first product is the Telcare BGM®, a cellular-enabled blood glucose meter for patients with diabetes. In addition to helping reduce the cost of care by improving outcomes and preventing complications, Telcare creates an ecosystem of care that provides caregivers and disease managers with previously unavailable actionable clinical data. Telcare is a privately-held company funded by the Qualcomm Life Fund, Sequoia Capital and founding investors. For more information, visit www.telcare.com.
|1||American Diabetes Association, Economic costs of diabetes in the U.S. in 2012, Diabetes Care, 2013;36:1033–46.|
|2||Diabetes Control and Complications Trial/Epidemiology of diabetes interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 2005;353:2643–53.|
|3||Eastman RC, Javitt JC, Herman WH, et al., Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia, Diabetes Care, 1997;20:725–34.|
|4||Javitt, JC, Reese CS, Derrick MK, Deployment of an mHealth Patient Monitoring Solution for Diabetes – Improved glucose monitoring leads to reduction in medical expenditure. US Endocrinol 2014, Winter Ed, pp. 119-123.|